ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

Jihui Hao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5598-6706. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2022: 1 paper

Papers 1

ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis. Last author DOI 10.1038/s41416-022-01927-y ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shengyu Yang · 1 shared paper, 2022 · strength 0.13
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y ↗
Fanjie Jin · 1 shared paper, 2022 · strength 0.13
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y ↗
Chongbiao Huang · 1 shared paper, 2022 · strength 0.13
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y ↗
Zhe Liu · 1 shared paper, 2022 · strength 0.13
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y ↗
Xiuchao Wang · 1 shared paper, 2022 · strength 0.13
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y ↗
Song Gao · 1 shared paper, 2022 · strength 0.13
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y ↗
Chuntao Gao · 1 shared paper, 2022 · strength 0.13
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y ↗
Tiansuo Zhao · 1 shared paper, 2022 · strength 0.13
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y ↗
Wenrun Cai · 1 shared paper, 2022 · strength 0.13
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y ↗
Jing Liu · 1 shared paper, 2022 · strength 0.13
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.